Login
$MBX
$53.12 -$2.82 (5.04%) Live

Insider Transactions

What MBX Biosciences, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 1
Sells 2 7
Total trades 2 17

Shares traded

3 months 12 months
Acquired 0 293,459
Disposed 5,266 76,477
Net activity −5,266 +216,982

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Hoerter Steven L. Chairman, President and CEO Nov 10 Sale for tax withholding · S −4,893 $54.82 −$268K 78,045
Azoulay Salomon Chief Medical Officer Nov 04 Sale for tax withholding · S −373 $53.96 −$20.1K 14,026
Azoulay Salomon Chief Medical Officer Aug 04 Sale for tax withholding · S −370 $65.77 −$24.3K 14,399
Smither John W Chief Financial Officer Aug 03 Grant / award · A +28,000 — — 28,000
Hoerter Steven L. President and CEO Aug 03 Grant / award · A +71,000 — — 82,938
Azoulay Salomon Chief Medical Officer May 08 Disclosed 10b5-1 sale · S −15,003 $38.30 −$575K 14,769
Azoulay Salomon Chief Medical Officer May 08 Exercise / conversion · M +15,003 $16.00 +$240K 29,772
Azoulay Salomon Chief Medical Officer May 08 Disclosed 10b5-1 sale · S −55,000 $38.38 −$2.11M 14,769
Azoulay Salomon Chief Medical Officer May 08 Exercise / conversion · M +55,000 $10.46 +$575K 69,769
Hawryluk P. Kent President & CEO May 06 Open-market sale · S −607 $29.54 −$17.9K 727,667
Azoulay Salomon Chief Medical Officer May 06 Sale for tax withholding · S −231 $29.54 −$6.82K 14,769
Hoerter Steven L. Director May 01 Grant / award · A +11,938 — — 11,938
Hawryluk P. Kent President & CEO Mar 13 Open-market buy · P +18,500 $28.41 +$526K 486,777
Hawryluk P. Kent President & CEO Feb 26 Exercise / conversion · M +28,768 $16.00 +$460K 728,274
Hawryluk P. Kent President & CEO Feb 02 Grant / award · A +35,250 — — 699,506
Bartram Richard Chief Financial Officer Feb 02 Grant / award · A +15,000 — — 15,000
Azoulay Salomon Chief Medical Officer Feb 02 Grant / award · A +15,000 — — 15,000
Hawryluk P. Kent President & CEO Oct 24 Exercise / conversion · M +182,859 $3.25 +$594K 664,256
Hawryluk P. Kent President & CEO Oct 20 Open-market buy · P +20,000 $13.64 +$273K 468,277
Hoerter Steven L. Director Oct 17 Open-market buy · P +20,000 $13.25 +$265K 20,000

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support